Re-augmentation of the Axilla Using a Turn-Over Flap – a New Approach for the Surgical Treatment of Secondary Lymphedema After Breast Cancer

Introduction Scarring and volume reduction of the axillary space resulting in persistent lymphedema is a side effect of axillary treatment in breast cancer patients. The aim of this paper is to describe the reduction of lymphedema achieved with a turnover flap. Materials and Methods Between October 2016 and May 2018, five patients with grade 2 lymphedema following breast cancer therapy underwent reconstructive surgery with a turnover flap. Complete excision of the symptomatic axillary scar tissue followed by re-augmentation using a turnover flap was performed. Subsequently, all patients underwent breast reconstruction using a distant flap reconnected to the thoracodorsal vessels. The circumference of both arms, quality of life and pain were measured before and after surgery. Results An average reduction in pain in the ipsilateral arm from 6 to 1 on the numerical scale as well as an improvement in quality of life (2.8 vs. 7.0) was observed. A decrease in lymphedema especially in the upper arm was identified. No complications such as secondary bleeding, infections or flap loss were observed. Conclusion Complete removal of the axillary scar tissue after breast cancer treatment and re-augmentation of the axilla with a turnover flap results in a reduction in ipsilateral lymphedema and an improvement in pain and quality of life. We interpret these findings as a result of the physiological re-alignment of the lymphatic vessels combined with a lymph node-containing local transposition flap. Therefore, re-augmentation with a turnover flap could be an effective non-microsurgical alternative to lymph node transplantation.

[1]  M. Cheng,et al.  Comparisons of Submental and Groin Vascularized Lymph Node Flaps Transfer for Breast Cancer-Related Lymphedema , 2018, Plastic and reconstructive surgery. Global open.

[2]  M. Cheng,et al.  Vascularized lymph node transfer for treatment of extremity lymphedema: An overview of current controversies regarding donor sites, recipient sites and outcomes , 2018, Journal of surgical oncology.

[3]  L. Snetselaar,et al.  Lymphedema following breast cancer: The importance of surgical methods and obesity. , 2018, Frontiers in women's health.

[4]  L. Zou,et al.  The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study , 2018, Breast Cancer.

[5]  L. Pavlidis,et al.  Donor-Site Lymphedema Following Lymph Node Transfer for Breast Cancer-Related Lymphedema: A Systematic Review of the Literature. , 2017, Lymphatic research and biology.

[6]  Hung-Chi Chen,et al.  Double gastroepiploic vascularized lymph node tranfers to middle and distal limb for the treatment of lymphedema , 2017, Microsurgery.

[7]  S. Mclaughlin,et al.  Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic Options , 2017, Annals of Surgical Oncology.

[8]  S. Mclaughlin,et al.  Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel , 2017, Annals of Surgical Oncology.

[9]  M. Cheng,et al.  Greater Omental Lymph Node Flap for Upper Limb Lymphedema with Lymph Nodes–depleted Patient , 2017, Plastic and reconstructive surgery. Global open.

[10]  A. Mafra da Costa,et al.  Risk Factors for Arm Lymphedema in a Cohort of Breast Cancer Patients Followed up for 10 Years , 2015, Breast Care.

[11]  C. Becker Autologous Lymph Node Transfers , 2015, Journal of Reconstructive Microsurgery.

[12]  J. Wallmichrath,et al.  Microsurgical Lymphatic Vessel Transplantation , 2015, Journal of Reconstructive Microsurgery.

[13]  M. Skolny,et al.  Lymphedema following breast cancer treatment and impact on quality of life: a review. , 2014, Critical reviews in oncology/hematology.

[14]  B. Newman,et al.  Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. , 2013, The Lancet. Oncology.

[15]  S. Vignes,et al.  Complications of autologous lymph-node transplantation for limb lymphoedema. , 2013, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[16]  S. Rockson,et al.  Estimating the Population Burden of Lymphedema , 2008, Annals of the New York Academy of Sciences.

[17]  M. Riquet,et al.  Postmastectomy Lymphedema: Long-term Results Following Microsurgical Lymph Node Transplantation , 2006, Annals of surgery.

[18]  B. Newman,et al.  Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up , 2005, Breast Cancer Research and Treatment.

[19]  F. Neil Wetzig MB BS,et al.  Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? Five-Year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial: Assessment and Incidence of True Lymphedema , 2016, Annals of Surgical Oncology.

[20]  V. Keeley,et al.  A quality of life measure for limb lymphoedema (LYMQOL) , 2010 .

[21]  M. Miller,et al.  Postmastectomy Lymphedema: Long-Term Results Following Microsurgical Lymph Node Transplantation , 2007 .

[22]  D. Hahn,et al.  Experimental basis and first application of clinical lymph vessel transplantation of secondary lymphedema , 2005, World Journal of Surgery.